on MeVis Medical Solutions AG (isin : DE000A0LBFE4)
MeVis Medical Solutions AG Reports First Half Fiscal Results for 2024/2025
Bremen, May 27, 2025 - MeVis Medical Solutions AG, a leader in medical imaging software, revealed its performance for the first half of fiscal year 2024/2025. The company reported revenues of €8,438 thousand, slightly down from €8,774 thousand the previous year. License sales contributed 22%, maintenance 34%, and other revenues 44% of the total.
EBIT decreased to €1,853 thousand from €2,092 thousand, with an EBIT margin of 22%. This decline is attributed to reduced sales and increased personnel costs. Income from financial loans reached €550 thousand, resulting in pre-tax earnings of €2,468 thousand compared to €2,735 thousand last year.
As per their forecast, MeVis expects steady to slight growth in sales, targeting €17.0 to €17.5 million for the year. The company anticipates stable development services and modest increases in lung and liver segment sales. Projected EBIT ranges from €3.5 to €4.0 million.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MeVis Medical Solutions AG news